-
1Academic Journal
Authors: S. E. Evstifeeva, S. A. Shalnova, A. D. Deev, T. M. Gatagonova, A. Yu. Efanov, Yu. V. Zhernakova, V. A. Il'in, A. O. Konradi, V. A. Metelskaya, E. V. Oschchepkova, S. V. Romanchuk, O. P. Rotar, I. A. Trubacheva, E. V. Shlyakhto, S. A. Boytsov
Source: Рациональная фармакотерапия в кардиологии, Vol 10, Iss 6, Pp 597-605 (2015)
Subject Terms: исследование ЭССЕ-РФ, распространенность, ассоциации, вялотекущее воспаление, высокочувствительный С-рекактивный белок, факторы риска, заболевания, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701
File Description: electronic resource
-
2Academic Journal
Authors: A.O. Konradi, V. A. Il'in, T. M. Gatagonova, V A Metelskaya, Evgeny Shlyakhto, E. V. Oschchepkova, Svetlana V. Romanchuk, S. A. Shalnova, O. P. Rotar, Sergey Boytsov, Yu V Zhernakova, I. A. Trubacheva, A. D. Deev, S. E. Evstifeeva, A. Yu. Efanov
Source: Рациональная фармакотерапия в кардиологии, Vol 10, Iss 6, Pp 597-605 (2015)
Subject Terms: 2. Zero hunger, 4. Education, вялотекущее воспаление, распространенность, высокочувствительный С-рекактивный белок, заболевания, факторы риска, RM1-950, ассоциации, исследование ЭССЕ-РФ, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, RC666-701, Diseases of the circulatory (Cardiovascular) system, Therapeutics. Pharmacology
Access URL: http://www.rpcardio.com/jour/article/download/278/292
https://doaj.org/article/1b5b067dac0847b99e4dcaf887fdb025
https://doaj.org/article/9b7147a4e3ae4317ac8081568171105c
https://www.rpcardio.com/jour/article/download/278/292
https://doaj.org/article/1b5b067dac0847b99e4dcaf887fdb025
https://core.ac.uk/display/87816499
https://www.rpcardio.com/jour/article/view/278 -
3Academic Journal
Authors: S. Evstifeeva E., S. Shalnova A., A. Deev D., T. Gatagonova M., A. Efanov Yu., Yu. Zhernakova V., V. Il'in A., A. Konradi O., V. Metelskaya A., E. Oschchepkova V., S. Romanchuk V., O. Rotar P., I. Trubacheva A., E. Shlyakhto V., S. Boytsov A., С. Евстифеева Е., С. Шальнова А., А. Деев Д., Т. Гатагонова М., А. Ефанов Ю., Ю. Жернакова В., В. Ильин А., А. Конради О., В. Метельская А., Е. Ощепкова В., С. Романчук В., О. Ротарь П., И. Трубачева А., Е. Шляхто В., С. Бойцов А.
Source: Rational Pharmacotherapy in Cardiology; Vol 10, No 6 (2014); 597-605 ; Рациональная Фармакотерапия в Кардиологии; Vol 10, No 6 (2014); 597-605 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2014-10-6
Subject Terms: исследование ЭССЕ-РФ, распространенность, ассоциации, вялотекущее воспаление, высокочувствительный С-рекактивный белок, факторы риска, заболевания
File Description: application/pdf
Relation: https://www.rpcardio.com/jour/article/view/278/292; Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010;55:1169-77.; Danesh J, Whincup P, Walker M, et al. Low grade infl ammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.; Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132-40.; Pearson T, Mensah G, Alexander R, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.; Scientific and Organizing Committee of the Russian Federation essay. The epidemiology of cardiovascular disease in different regions of Russia (ESSE-RF). Rationale and design of the study. Profilakticheskaya Meditsina 2013; 6: 25-34. Russian (Научно-организационный комитет проекта ЭССЕ-РФ. Эпидемиология сердечно-сосудистых заболеваний в различных регионах России (ЭССЕ-РФ). Обоснование и дизайин исследований. Профилактическая Медицина 2013;6:25-34).; Ridker PM. C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease. Clinical Chemistry 2009;55:2 209-15.; Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med 2005;352:1611-3.; Wang Z, Hoy WE. Population Distribution Of High Sensitivity C-Reactive Protein Values in Aboriginal ustralians: A Comparison With Other Populations. Clin Biochem 2006;39(3):277-81.; Hutchinson WL, Koenig W, Frohlich M, et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934-8.; Albert MA Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003;108:161-5.; Ford E, Giles W, Myers G, et al Mannino DM. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999–2000. Clin Chem 2003;49:1353-7.; Nasermoaddel A, Sekine M. Kagamimori S. Gender Differences in Associations of C-Reactive Protein With Atherosclerotic Risk Factors and Psychosocial haracteristics in Japanese Civil Servants. Psychosomatic Medicine 2006;68:1:58-63.; Marques-Vidal P, Mazoyer E, Bongard V, et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002;25:1371-7.; Imhof A, Frohlich M, Loewel H, et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem 2003;49:669-72.; Winston H, Koenig W, Frohlich M. Immunoradiometric Assay of Circulating C-Reactive Protein: Agerelated Values in the Adult General Population. Clinical Chemistry 2000;46:7 934-8.; Loucks EB, Sullivan LM, Hayes LJ, et al. Association of Educational Level with Inflammatory Markers in the Framingham Offspring Study. Am J Epidemiol 2006:163:7:622-8.; Nazmi A, Victora C. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 2007;7:212.; Dhingra R, Gona P, Nam BH, et al. С-Reactive Protein, Inflammatory Conditions and Cardiovascular Disease Risk. Am J Med 2007;120:12: 1054-62.; Loucks EB, Sullivan L, Hayes L, et al. Association of Educational Level with Inflammatory Markers in the Framingham Offspring Study. Am J Epidemiol 2006;163:7:622-8.; Zhukova VA, Shalnova SA, Metelskaya VA, et al. The results of population-based study "Stress, aging and health in Russia". Kremlevskaya meditsina. Klinicheskiy Vestnik 2012: 1: 136-8. Russian (Жукова В.А., Шальнова С.А., Метельская В.А., и др. Результаты популяционного исследования «Стресс, старение и здоровье в России». Кремлевская медицина. Клинический Вестник 2012:1;136-8).; Wannamethee S, Lowe G, Shaper A, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26(17):1765-73.; Averina M, Nilssen O, Arkhipovsky V, et al. C-reactive protein and alcohol consumption: Is there a Ushaped association? Results from a population-based study in Russia The Arkhangelsk study. Atherosclerosis 2006;188:309-15.; Han T, Sattar N, Williams K, et al. Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study. Diabetes Care 2002;25:2016-21.; Laaksonen D, Niskanen L, Nyyssonen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004;47:1403-10.; Ford E. Body Mass Index, Diabetes, and C-Reactive Protein Among U.S. Adults. Diabetes Care 1999;22:1971-7.; Grundy S. Obesity, metabolite syndrome and coronary atherosclerosis. Circulation 2002;105:26-98.; Indulekha K, Surendar J, Mohan V. C-Reactive Protein, Tumor Necrosis Factor-α, Interleukin-6, and Vascular Cell Adhesion Molecule-1 Levels in Asian Indians with Metabolic Syndrome and Insulin Resistance (CURES-105). J Diabetes Sci Technol 2011;5:4:982-8.; Morrow D, Lemos J. Benchmarks for the Assessment of Novel Cardiovascular Biomarkers. Circulation 2007;115:949-52.; Sesso HD, Burning GE, Rafai N, et al. C-reactive protein and the risk of development hypertension. JAMA 2003;290:2945-51.; Bautista LE, Vera LM, Arenas IA, et al. Independent association between inflammatory markers (Creactive protein, interleukin 6 and TNF-alpha) and essential hypertension. J Hum Hypertens 2005; 19 (2): 149-54.; Cifcova R, Frohlich J, Skodova Z, et al. C-reactive protein and the risk of developing hypertension. A population study. J Hypertens 2004;22:262.; Zacho J, Tybjærg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. October 30, 2008;359:1897-908.; Ridker P, Charles H, Hennekens M, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.; Bekbosynova MS, Nikitina TY, Golitsyn SP, et al. The level of C-reactive protein and the incidence of autoantibodies against β1-adrenoceptor in patients with supraventricular tachyarrhythmias. Kardiologiya 2006; 7: 55-61. Russian (Бекбосынова М.С., Никитина Т.Я., Голицин С.П. и др. Уровень С-реактивного белка и частота выявления аутоантител к β1-адренорецепторам у больных с наджелудочковыми тахиаритмиями. Кардиология 2006;7:55-61).; de Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:5:902-7.; https://www.rpcardio.com/jour/article/view/278
-
4Academic Journal
Authors: Евстифеева, Светлана, Шальнова, Светлана, Деев, Александр, Гатагонова, Тамара, Ефанов, Алексей, Жернакова, Юлия, Ильин, Владимир, Конради, Александра, Метельская, Виктория, Ощепкова, Елена, Романчук, Светлана, Ротарь, Оксана, Трубачева, Ирина, Шляхто, Евгений, Бойцов, Сергей, Баланова, Юлия, Гомыранова, Наталия, Капустина, Анна, Концевая, Анна, Литинская, Ольга, Мамедов, Мехман, Муромцева, Галина, Оганов, Рафаэль, Суворова, Евгения, Худяков, Михаил, Баранова, Елена, Касимов, Риза, Шабунова, Александра, Калашников, Константин, Калачикова, Ольга, Кондакова, Н., Попов, Андрей, Устинова, К., Белова, Ольга, Назарова, Ольга, Шутемова, Е., Кавешников, Владимир, Карпов, Ростислав, Серебрякова, Виктория, Медведева, Ирина, Сторожок, Марина, Шава, Владимир, Шалаев, Сергей, Гутнова, Светлана, Толпаров, Георгий
Subject Terms: ИССЛЕДОВАНИЕ ЭССЕ-РФ, РАСПРОСТРАНЕННОСТЬ, АССОЦИАЦИИ, ВЯЛОТЕКУЩЕЕ ВОСПАЛЕНИЕ, ВЫСОКОЧУВСТВИТЕЛЬНЫЙ С-РЕКАКТИВНЫЙ БЕЛОК, ФАКТОРЫ РИСКА, ЗАБОЛЕВАНИЯ
File Description: text/html
-
5Academic Journal
Source: Рациональная фармакотерапия в кардиологии.
Subject Terms: ИССЛЕДОВАНИЕ ЭССЕ-РФ, РАСПРОСТРАНЕННОСТЬ, АССОЦИАЦИИ, ВЯЛОТЕКУЩЕЕ ВОСПАЛЕНИЕ, ВЫСОКОЧУВСТВИТЕЛЬНЫЙ С-РЕКАКТИВНЫЙ БЕЛОК, ФАКТОРЫ РИСКА, ЗАБОЛЕВАНИЯ, 3. Good health
File Description: text/html